Company intelligence / Profile preview

Cetara Therapeutics

Princeton, New Jersey, United States

Ownership: Private
Employees: ~1200
Development stage: Other

Overview

Certara provides commercial biosimulation, model-informed drug development, regulatory, and market access software and services used across discovery, preclinical, clinical, and post-approval development, supporting regulatory submissions and approvals globally.[2][4]

Modalities: Non-pharmacological therapy
Industry: Drug Discovery Services

Partnerships

Biogen[4]Dizal[4]Numerous global biopharmaceutical companies, academic institutions, and regulatory agencies[2][4][5]

Beyond the preview

Go deeper on Cetara Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cetara Therapeutics.

Explore the full profile